RAD51 recruitment but not replication fork stability associates with PARP inhibitor response in ovarian cancer patient-derived xenograft models.
Talens F, Teixeira VON, Kok YP, Chen M, Rosenberg EH, Debipersad R, Duiker EW, van den Tempel N, Janatova M, Zemankova P, Nederlof PM, Wisman GBA, Kleibl Z, de Jong S, van Vugt MATM.
Talens F, et al. Among authors: de jong s.
NAR Cancer. 2024 Nov 28;6(4):zcae044. doi: 10.1093/narcan/zcae044. eCollection 2024 Dec.
NAR Cancer. 2024.
PMID: 39611179
Free PMC article.